Skip to Content
Top
Taxotere

Taxotere Lawsuits

Dangerous Drug Attorney in Louisville

Brett H. Oppenheimer, PLLC is currently evaluating consumer complaints involving Taxotere, a chemotherapy drug that has been linked with permanent hair loss (alopecia). Taxotere is most commonly prescribed for the treatment of breast cancer and metastatic prostate cancer. While hair loss is a common side effect of chemotherapy, numerous patients across the nation have reported that their hair never grew back after treatment involving Taxotere.

Our firm believes that negligent drug companies should be held fully responsible when their products harm innocent people. If you or a loved one has suffered permanent loss of hair after taking this defective drug, you may be entitled to compensation. We encourage you to contact our firm to learn if you have a viable product liability case, how much your case may be worth, and what legal options are available to you.

Our Louisville Taxotere lawyer has more than 25 years of experience advocating for the injured and has successfully recovered millions of dollars in verdicts and settlements.

Sanofi-Aventis, the maker of Taxotere, is widely accused of failing to adequately warn patients and physicians of the increased risk of alopecia. All over the country, claims are being filed alleging that if Sanofi-Aventis had properly warned of the risks associated with the medication, patients could have been prescribed Taxol, a different and more effective chemotherapy drug that does not carry an alopecia risk.

Taxotere has also been linked to the following additional side effects:

  • Nausea
  • Taste changes
  • Bone, muscle, or joint pain
  • Mouth or throat sores
  • Weakness and fatigue
  • Weight gain with fluid retention
  • Peripheral neuropathy

Evidence is alleged to have shown that Sanofi knew of the permanent hair loss caused by Taxotere, yet it continued to aggressively push the product. The company stated that Taxotere was better than other chemotherapy treatment products, and focused on creating sales instead of on protecting the wellbeing of patients. If you or a loved one have suffered hair loss or other serious medical conditions due to Taxotere, we can help you file a claim and pursue compensation from the manufacturer.

Current lawsuits against Sanofi SA include claims regarding:

  • Deceptive marketing practices
  • Downplaying the risks and side effects of Taxotere
  • Misrepresentation

Do You Have a Claim? Call Brett H. Oppenheimer, PLLC Today at (502) 242-8877.

At Brett H. Oppenheimer, PLLC, we have guided numerous clients through the Kentucky legal system. If you have sustained permanent and unnecessary hair loss from using Taxotere, we can fight on your behalf. Sanofi SA must be held responsible for fraudulent marketing practices and for failing to warn consumers about the side effects of its product. Our Louisville dangerous drug lawyer can investigate your situation and gather evidence to build your case.

Contact us to speak with our reliable injury attorney, and learn how our services can help.

Clients Believe Brett Oppenheimer Is the Right Choice

  • I was able to focus on my son & his healing while you all handled all the grit & grime.

    Yvonne Cunningham
  • Outstanding Professionals!

    Current Client
  • I truly sincerely value & greatly appreciate Brett & his team.

    Darren H.

You Can Count on Brett

  • Respected by His Peers, Loved by His Clients
  • Over 30 Years of Legal Experience
  • Personal Involvement From Start to Finish
  • No Recovery, No Fee

Contact Us

All Consultations Are Free & Confidential
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy